T61848
|
|
|
Others
|
Rosiglitazone (BRL 49653) potassium is a potent and selective PPARγ agonist (EC 50: 60 nM, Kd: 40 nM), administered orally. It also serves as an activator of TRPC5 (EC 50: 30 μM) and an inhibitor of TRPM3. This compound, widely used in research, has shown promise in investigating obesity, diabetes, senescence, and ovarian cancer [1] [2] [4] [7]. |
T0334
|
|
|
Ferroptosis
TRP/TRPV Channel
PPAR
Autophagy
|
Rosiglitazone (BRL49653) 是一种 PPARγ 激动剂、TRPC5 激活剂和 TRPM3 抑制剂,具有口服活性。Rosiglitazone 也是一种降糖剂,是噻唑烷二酮类胰岛素增敏剂。 |
T1622
|
|
|
Ferroptosis
TRP/TRPV Channel
PPAR
Autophagy
|
Rosiglitazone maleate (BRL 49653) 是一种选择性PPARγ激活剂,具有抗糖尿病特性和潜在抗肿瘤活性。它也是TRP 通道调节剂,可抑制 TRPM2、TRPM3 的活性,激活 TRPC5。 |
T6646
|
|
|
Ferroptosis
TRP/TRPV Channel
PPAR
Autophagy
|
Rosiglitazone hydrochloride (BRL-49653 HCl) 是一种降血糖药物,通过与脂肪细胞中的 PPAR 受体结合来刺激胰岛素分泌。它对 PPARγ1、PPARγ2 和 PPARγ 的EC50值分别为 30 nM、100 nM 和 60 nM。它也是TRPC5的激活剂和TRPM3的抑制剂。 |